Andrea Carpenter, APRN
Nurse Practitioner · Tulsa, OKNPI 1336794650
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,503 of the $7,492 with a category attached, or 86.8%. It is spread thinly across 40 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 243 payments — averaging $30.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- GSK$438
- Astellas Pharma US Inc$425
- Daiichi Sankyo Inc.$345
- Merck$276
- plus $3K from 34 others
What the payments were for
- Consulting fees$4386%
- Food & beverage$6,50387%
- Education$5517%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 34 | $1,696 |
| AbbVie | 35 | $1,329 |
| GSK | 21 | $438 |
| Astellas Pharma US Inc | 16 | $425 |
| Daiichi Sankyo Inc. | 13 | $345 |
| Merck | 10 | $276 |
| Seagen Inc. | 4 | $248 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $229 |
| Pfizer | 7 | $218 |
| Incyte Corporation | 3 | $211 |
| Boehringer Ingelheim | 15 | $195 |
| Regeneron Healthcare Solutions, Inc. | 6 | $179 |
| Eisai Inc. | 11 | $177 |
| Lilly USA, LLC | 6 | $176 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $168 |
| Biohaven Pharmaceuticals, Inc. | 4 | $165 |
| Genmab U.S., Inc. | 7 | $159 |
| E.r. Squibb & Sons, L.L.C. | 2 | $157 |
| Novartis | 6 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Novo Nordisk | 4 | $59 |
| AVEO Pharmaceuticals, Inc. | 2 | $53 |
| Johnson & Johnson(2 entities) | 3 | $46 |
| CSL Behring | 2 | $36 |
| Genentech USA, Inc. | 2 | $35 |
| Alk-abello, Inc | 2 | $34 |
| ADC Therapeutics America, Inc. | 1 | $29 |
| BD | 1 | $24 |
| Pharmaessentia USA Corporation | 1 | $23 |
| Sanofi | 1 | $21 |
| Biocryst US Sales Co., LLC | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $19 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $17 |
| Organon | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Stemline Therapeutics Inc. | 1 | $15 |
| Geron Corporation | 1 | $15 |
| Teleflex LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,492 in reported general payments places this provider in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 27 | $212 |
| Potassium Chloride | 14 | $207 |
| Tramadol Hcl | 13 | $73 |
| Fluconazole | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Tulsa
- Jenny GuthrieTulsa$106K
- Stacy NewberryTulsa$28K
- Amanda SmallTulsa$14K
- Mindi PriceTulsa$11K
- Huong HuynhTulsa$10K
- Jonathan BouldinTulsa$10K
- Michelle LoeberTulsa$10K
- Erin WilliamsonTulsa$9K
- Charles SpradlinTulsa$7K
- Leslie BurtonTulsa$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.